减毒活疫苗脊髓灰质炎疫苗的现状。 - Suppr

Suppr

超能文献

Present status of attenuated live virus poliomyelitis vaccine.

作者信息

SABIN A B

出版信息

Bull N Y Acad Med. 1957 Jan;33(1):17-39.

PMID:13383294

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1806054/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6253/1806054/9e41cba9c732/bullnyacadmed00370-0050-a.jpg

相似文献

Present status of attenuated live virus poliomyelitis vaccine.减毒活疫苗脊髓灰质炎疫苗的现状。

Bull N Y Acad Med. 1957 Jan;33(1):17-39.

Present status of attenuated live-virus poliomyelitis vaccine.减毒活疫苗脊髓灰质炎疫苗的现状。

J Am Med Assoc. 1956 Dec 29;162(18):1589-96. doi: 10.1001/jama.1956.02970350005002.

Vaccination against poliomyelitis with live virus vaccines. II. A trial of SM type I attenuated poliomyelitis virus vaccine.使用活病毒疫苗预防脊髓灰质炎。II. I型SM株减毒脊髓灰质炎病毒疫苗的试验。

Br Med J. 1957 Jan 12;1(5010):65-70.

Vaccination against poliomyelitis with live virus vaccines. I. A trial of TN type II vaccine.使用活病毒疫苗进行脊髓灰质炎疫苗接种。I. TN II型疫苗的试验。

Br Med J. 1957 Jan 12;1(5010):59-65.

[Vaccination in Poland with a live attenuated vaccine against poliomyelitis].[在波兰接种减毒活脊髓灰质炎疫苗]

Med Dosw Mikrobiol. 1960;12:1-14.

Poliomyelitis in Idaho after use of live virus vaccine.使用活病毒疫苗后爱达荷州的脊髓灰质炎疫情

Public Health Rep (1896). 1958 Jul;73(7):637-47.

Historical aspects of the development of live virus vaccine in poliomyelitis.脊髓灰质炎减毒活疫苗发展的历史概况。

Br Med J. 1960 Jul 9;2(5192):85-91. doi: 10.1136/bmj.2.5192.85.

Live attenuated poliomyelitis vaccine.减毒活脊髓灰质炎疫苗

Public Health Rep (1896). 1959 May;74(5):382.

Vaccination against poliomyelitis with live virus vaccines. III. The evaluation to TN and SM virus vaccines.使用活病毒疫苗预防脊髓灰质炎。III. 对TN和SM病毒疫苗的评估。

Br Med J. 1957 Jan 12;1(5010):70-4.

[Present state of field experiments with oral attenuated live poliomyelitis vaccine].[口服减毒活脊髓灰质炎疫苗现场试验的现状]

Cesk Pediatr. 1960 Jan 5;15:10-6.

引用本文的文献

Who Is the Intermediate Host of RNA Viruses? A Study Focusing on SARS-CoV-2 and Poliovirus.谁是RNA病毒的中间宿主？一项聚焦于新冠病毒和脊髓灰质炎病毒的研究。

Microorganisms. 2024 Mar 23;12(4):643. doi: 10.3390/microorganisms12040643.

Analysis of Bacteriophage Behavior of a Human RNA Virus, SARS-CoV-2, through the Integrated Approach of Immunofluorescence Microscopy, Proteomics and D-Amino Acid Quantification.通过免疫荧光显微镜、蛋白质组学和 D-氨基酸定量分析综合方法分析人类 RNA 病毒 SARS-CoV-2 的噬菌体行为。

Int J Mol Sci. 2023 Feb 15;24(4):3929. doi: 10.3390/ijms24043929.

Could SARS-CoV-2 Have Bacteriophage Behavior or Induce the Activity of Other Bacteriophages?严重急性呼吸综合征冠状病毒2（SARS-CoV-2）会具有噬菌体行为或诱导其他噬菌体的活性吗？

Vaccines (Basel). 2022 Apr 29;10(5):708. doi: 10.3390/vaccines10050708.

Minimum Infective Dose of the Major Human Respiratory and Enteric Viruses Transmitted Through Food and the Environment.通过食物和环境传播的主要人类呼吸道和肠道病毒的最小感染剂量

Food Environ Virol. 2011 Mar;3(1):1-30. doi: 10.1007/s12560-011-9056-7. Epub 2011 Mar 16.

Plant-made polio type 3 stabilized VLPs-a candidate synthetic polio vaccine.植物源3型脊髓灰质炎稳定病毒样颗粒——一种候选合成脊髓灰质炎疫苗。

Nat Commun. 2017 Aug 15;8(1):245. doi: 10.1038/s41467-017-00090-w.

Translational Research in the Nonhuman Primate Model of Tuberculosis.结核病非人灵长类动物模型的转化研究

ILAR J. 2017 Dec 1;58(2):151-159. doi: 10.1093/ilar/ilx015.

STUDIES WITH RHINOVIRUSES IN VOLUNTEERS: PRODUCTION OF ILLNESS, EFFECT OF NATURALLLY ACQUIRED ANTIBODY, AND DEMONSTRATION OF A PROTECTIVE EFFECT NOT ASSOCIATED WITH SERUM ANTIBODY.志愿者鼻病毒研究：疾病的产生、自然获得抗体的影响以及与血清抗体无关的保护作用的证明

J Clin Invest. 1964 Jan;43(1):56-67. doi: 10.1172/JCI104894.

Poliovirus precipitins; a study by means of diffusion in agar.脊髓灰质炎病毒沉淀素；琼脂扩散法研究

J Exp Med. 1957 Nov 1;106(5):661-76. doi: 10.1084/jem.106.5.661.

The nature of viruses.病毒的本质。

Bull N Y Acad Med. 1957 Jun;33(6):397-404.

Differentiation of temperature variants of influenza A2 viruses on the basis of plaque formation.基于蚀斑形成对甲型流感病毒A2温度变异株的鉴别

J Virol. 1968 May;2(5):456-60. doi: 10.1128/JVI.2.5.456-460.1968.

本文引用的文献

Immune responses in human volunteers upon oral administration of a rodent-adapted strain of poliomyelitis virus.人类志愿者口服适应啮齿动物的脊髓灰质炎病毒株后的免疫反应。

Am J Hyg. 1952 Jan;55(1):108-24. doi: 10.1093/oxfordjournals.aje.a119499.

Poliomyelitis infection in immunized chimpanzees.免疫黑猩猩中的脊髓灰质炎感染。

Ann N Y Acad Sci. 1955 Sep 27;61(4):1014-20; discussion, 1020-2. doi: 10.1111/j.1749-6632.1955.tb42561.x.

Clinical investigations on attenuated strains of poliomyelitis virus; use as a method of immunization of children with living virus.脊髓灰质炎病毒减毒株的临床研究；用作儿童活病毒免疫方法。

J Am Med Assoc. 1956 Mar 17;160(11):954-66. doi: 10.1001/jama.1956.02960460032008.

Living attenuated poliomyelitis virus as an immunizing agent of man.减毒活脊髓灰质炎病毒作为人类免疫制剂

S Afr Med J. 1955 Oct 29;29(49):1134-42.

Plaque formation with poliomyelitis, Coxsackie, and orphan (echo) viruses in bottle cultures of monkey epithelial cells.在猴上皮细胞的瓶装培养物中，脊髓灰质炎病毒、柯萨奇病毒及孤儿（埃可）病毒形成蚀斑。

Virology. 1955 Dec;1(5):533-5. doi: 10.1016/0042-6822(55)90041-6.

[Present state of research on vaccination against poliomyelitis].[脊髓灰质炎疫苗接种的研究现状]

Brux Med. 1954 Jul 25;34(30):1413-26.

Studies on variants of poliomyelitis virus. I. Experimental segregation and properties of avirulent variants of three immunologic types.脊髓灰质炎病毒变种的研究。I. 三种免疫类型无毒力变种的实验分离及特性

J Exp Med. 1954 Jun 1;99(6):551-76. doi: 10.1084/jem.99.6.551.

Plaque formation and isolation of pure lines with poliomyelitis viruses.脊髓灰质炎病毒的噬斑形成及纯系分离

J Exp Med. 1954 Feb;99(2):167-82. doi: 10.1084/jem.99.2.167.

Poliomyelitis. II. Propagation of MEFI strain of poliomyelitis virus in developing chick embryo by yolk sac inoculation.脊髓灰质炎。二、脊髓灰质炎病毒MEFI株通过卵黄囊接种在发育中的鸡胚中增殖

Proc Soc Exp Biol Med. 1952 Nov;81(2):519-25. doi: 10.3181/00379727-81-19928.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验